{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:53:56Z","timestamp":1791971636095,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"vor","delay-in-days":262,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.aicoj.2026.100164","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:27:04Z","timestamp":1790004424000},"page":"100164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early piperacillin exposure during continuous infusion in critically ill patients: the impact of renal and liver dysfunctions"],"prefix":"10.1016","volume":"16","author":[{"given":"Matthieu","family":"Conseil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e8s","family":"Lakbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Laurino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suheda","family":"Evsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Monet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouad","family":"Belafia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Capdevila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Joseph","family":"Bendjilali-Sabiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald","family":"Chanques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"De Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoann","family":"Cazaubon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aicoj.2026.100164_bib0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.aicoj.2026.100164_bib0010","doi-asserted-by":"crossref","first-page":"e2013","DOI":"10.1016\/S2214-109X(25)00356-0","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2021: a systematic analysis","volume":"13","author":"Gray","year":"2025","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.aicoj.2026.100164_bib0015","article-title":"Septic shock: incidence, mortality and hospital readmission rates in French intensive care units from 2014 to 2018","volume":"41","author":"Lakbar","year":"2022","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.aicoj.2026.100164_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95852-4","article-title":"Association between mortality and highly antimicrobial-resistant bacteria in intensive care unit-acquired pneumonia","volume":"11","author":"Lakbar","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.aicoj.2026.100164_bib0025","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aicoj.2026.100164_bib0030","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","article-title":"Time to treatment and mortality during mandated emergency care for sepsis","volume":"376","author":"Seymour","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aicoj.2026.100164_bib0035","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciu027","article-title":"DALI: defining antibiotic levels in intensive care unit patients: are current \u03b2-lactam antibiotic doses sufficient for critically ill patients?","volume":"58","author":"Roberts","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.aicoj.2026.100164_bib0040","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/cc9091","article-title":"Insufficient \u03b2-lactam concentrations in the early phase of severe sepsis and septic shock","volume":"14","author":"Taccone","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.aicoj.2026.100164_bib0045","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.aicoj.2026.100164_bib0050","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/antibiotics14060622","article-title":"The effect of antibiotics on the nervous system: importance for anesthesiology and intensive care","volume":"14","author":"Radkowski","year":"2025","journal-title":"Antibiotics"},{"key":"10.1016\/j.aicoj.2026.100164_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9071505","article-title":"Beta-lactams toxicity in the intensive care unit: an underestimated collateral damage?","volume":"9","author":"Roger","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.aicoj.2026.100164_bib0060","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00134-025-07822-3","article-title":"Antibiotic dosing optimization in critically ill patients","volume":"51","author":"Koulenti","year":"2025","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.aicoj.2026.100164_bib0065","article-title":"Pharmacokinetic-pharmacodynamic target attainment with continuous infusion piperacillin in patients admitted to the ICU with hospital-acquired pneumonia","author":"Zurawska","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.aicoj.2026.100164_bib0070","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2020.2717","article-title":"Prevalence and outcomes of infection among patients in intensive care units in 2017","volume":"323","author":"Vincent","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.aicoj.2026.100164_bib0075","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.aicoj.2026.100164_bib0080","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.2024.9779","article-title":"Continuous vs intermittent \u03b2-lactam antibiotic infusions in critically ill patients with sepsis: the BLING III Randomized Clinical Trial","volume":"332","author":"Dulhunty","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.aicoj.2026.100164_bib0085","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/antibiotics13090801","article-title":"Risk factors associated with antibiotic exposure variability in critically ill patients: a systematic review","volume":"13","author":"Gras-Mart\u00edn","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.aicoj.2026.100164_bib0090","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1001\/jama.2025.20516","article-title":"Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score","volume":"334","author":"Ranzani","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.aicoj.2026.100164_bib0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13054-025-05736-6","article-title":"Beta-lactam dose reductions in critically ill patients with acute kidney injury: a scoping review","volume":"30","author":"Horstink","year":"2025","journal-title":"Crit Care"},{"key":"10.1016\/j.aicoj.2026.100164_bib0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/11539220-000000000-00000","article-title":"The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients","volume":"50","author":"Ulldemolins","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.aicoj.2026.100164_bib0105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/AAC.19.2.279","article-title":"Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis","volume":"19","author":"Giron","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.aicoj.2026.100164_bib0110","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","article-title":"Pharmacokinetic issues for antibiotics in the critically ill patient","volume":"37","author":"Roberts","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aicoj.2026.100164_bib0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ijantimicag.2007.12.009","article-title":"Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections","volume":"31","author":"McKinnon","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.aicoj.2026.100164_bib0120","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1093\/jac\/dkx209","article-title":"Too much of a good thing: a retrospective study of \u03b2-lactam concentration-toxicity relationships","volume":"72","author":"Imani","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.aicoj.2026.100164_bib0125","unstructured":"European Committee on Antimicrobial Susceptibility Testing: MIC and Zone Distributions, ECOFFs [Internet]. EUCAST [cited 2025 Dec 15] Available from: https:\/\/www.eucast.org\/bacteria\/mic-and-zone-distributions-ecoffs\/. Accessed 15 Dec 2025."},{"key":"10.1016\/j.aicoj.2026.100164_bib0130","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s13054-019-2663-7","article-title":"The SOFA score-development, utility and challenges of accurate assessment in clinical trials","volume":"23","author":"Lambden","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.aicoj.2026.100164_bib0135","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.aicoj.2026.100164_bib0140","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s15010-019-01352-z","article-title":"Therapeutic drug monitoring-guided continuous infusion of piperacillin\/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience","volume":"47","author":"Richter","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.aicoj.2026.100164_bib0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jcrc.2019.04.013","article-title":"Early target attainment of continuous infusion piperacillin\/tazobactam and meropenem in critically ill patients: a prospective observational study","volume":"52","author":"Dhaese","year":"2019","journal-title":"J Crit Care"},{"key":"10.1016\/j.aicoj.2026.100164_bib0150","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijantimicag.2014.12.020","article-title":"Augmented renal clearance and therapeutic monitoring of \u03b2-lactams","volume":"45","author":"Udy","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.aicoj.2026.100164_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2015.06.002","article-title":"Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization","volume":"24","author":"Sime","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.aicoj.2026.100164_bib0160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ijantimicag.2017.11.013","article-title":"Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of \u03b2-lactams administered by continuous infusion: a prospective observational study","volume":"51","author":"Carri\u00e9","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.aicoj.2026.100164_bib0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40262-022-01198-z","article-title":"Population pharmacokinetics of piperacillin\/tazobactam across the adult lifespan","volume":"62","author":"Hemmersbach-Miller","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.aicoj.2026.100164_bib0170","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1365-2125.2010.03750.x","article-title":"Nonlinear pharmacokinetics of piperacillin in healthy volunteers - implications for optimal dosage regimens","volume":"70","author":"Bulitta","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.aicoj.2026.100164_bib0175","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s12630-023-02689-8","article-title":"Exposure levels and target attainment of piperacillin\/tazobactam in adult patients admitted to the intensive care unit: a prospective observational study","volume":"71","author":"El-Haffaf","year":"2024","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.aicoj.2026.100164_bib0180","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics12121674","article-title":"Predicting beta-lactam target non-attainment in ICU patients at treatment initiation: development and external validation of three novel (machine learning) models","volume":"12","author":"Wieringa","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.aicoj.2026.100164_bib0185","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1186\/s13054-020-03272-z","article-title":"Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT)","volume":"24","author":"Abdulla","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.aicoj.2026.100164_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-022-01196-1","article-title":"Pharmacokinetics and target attainment of \u00df-lactam antibiotics in older people: a systematic review of current literature","volume":"62","author":"Vervalcke","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.aicoj.2026.100164_bib0195","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/17425255.2021.1879049","article-title":"A narrative review of predictors for \u03b2-lactam antibiotic exposure during empirical treatment in critically ill patients","volume":"17","author":"Abdulla","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.aicoj.2026.100164_bib0200","article-title":"Optimization of antimicrobial therapy in critically ill patients, what clinicians and searchers must know","volume":"44","author":"Roger","year":"2025","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.aicoj.2026.100164_bib0205","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13613-020-00666-8","article-title":"Acute-on-chronic liver failure alters meropenem pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study","volume":"10","author":"Grensemann","year":"2020","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.aicoj.2026.100164_bib0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/antibiotics11010031","article-title":"Antibiotics and liver cirrhosis: what the physicians need to know","volume":"11","author":"Zoratti","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.aicoj.2026.100164_bib0215","unstructured":"European Medicines Agency (EMA). Tazocin - referral [Internet]. 2010 [cited 2026 Apr 20]. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/tazocin. Accessed 20 Apr 2026."},{"key":"10.1016\/j.aicoj.2026.100164_bib0220","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1472-8206.1991.tb00768.x","article-title":"Pharmacokinetics and ascitic fluid penetration of piperacillin in cirrhosis","volume":"5","author":"Hary","year":"1991","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.aicoj.2026.100164_bib0225","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s40262-021-01102-1","article-title":"Biomarkers predicting tissue pharmacokinetics of antimicrobials in sepsis: a review","volume":"61","author":"Sanz Codina","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.aicoj.2026.100164_bib0230","doi-asserted-by":"crossref","first-page":"A401","DOI":"10.1186\/2197-425X-3-S1-A401","article-title":"B-lactams serum concentrations in critically ill cirrhotic patients: a matched-control study","volume":"3","author":"Lheureux","year":"2015","journal-title":"Intensive Care Med Exp"},{"key":"10.1016\/j.aicoj.2026.100164_bib0235","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/liv.13039","article-title":"Serum \u03b2-lactam concentrations in critically ill patients with cirrhosis: a matched case-control study","volume":"36","author":"Lheureux","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.aicoj.2026.100164_bib0240","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jointm.2023.12.007","article-title":"Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: a narrative review","volume":"4","author":"Roger","year":"2024","journal-title":"J Intensive Med"},{"key":"10.1016\/j.aicoj.2026.100164_bib0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165737","article-title":"Extrahepatic drug transporters in liver failure: focus on kidney and gastrointestinal tract","volume":"21","author":"Dro\u017adzik","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.aicoj.2026.100164_bib0250","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3748\/wjg.v27.i11.990","article-title":"Chronic renal dysfunction in cirrhosis: a new frontier in hepatology","volume":"27","author":"Kumar","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aicoj.2026.100164_bib0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.aucc.2025.101450","article-title":"Antibiotic residual drug error in the intensive care unit: a qualitative exploration of awareness, causes, and solutions","volume":"38","author":"Jarrett","year":"2025","journal-title":"Aust Crit Care"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582026001998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582026001998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:30:39Z","timestamp":1791970239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582026001998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":51,"alternative-id":["S2110582026001998"],"URL":"https:\/\/doi.org\/10.1016\/j.aicoj.2026.100164","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early piperacillin exposure during continuous infusion in critically ill patients: the impact of renal and liver dysfunctions","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aicoj.2026.100164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 de R\u00e9animation de Langue Fran\u00e7aise (French Intensive Care Society).","name":"copyright","label":"Copyright"}],"article-number":"100164"}}